ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacovigilance (PV) Outsourcing Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-25H5903
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacovigilance PV Outsourcing Market Insights Forecast to 2028
BUY CHAPTERS

Global Pharmacovigilance (PV) Outsourcing Market Insights, Forecast to 2030

Code: QYRE-Auto-25H5903
Report
December 2024
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Accenture Plc
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
Igate Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
ORACLE CORPORATION
PAREXEL
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen

Pharmacovigilance (PV) Outsourcing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacovigilance (PV) Outsourcing Market

Pharmacovigilance (PV) Outsourcing Market

Market Analysis and Insights: Global Pharmacovigilance (PV) Outsourcing Market
The global Pharmacovigilance (PV) Outsourcing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pharmacovigilance (PV) Outsourcing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmacovigilance (PV) Outsourcing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmacovigilance (PV) Outsourcing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmacovigilance (PV) Outsourcing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmacovigilance (PV) Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmacovigilance (PV) Outsourcing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pharmacovigilance (PV) Outsourcing Market Report

Report Metric Details
Report Name Pharmacovigilance (PV) Outsourcing Market
CAGR 5%
Segment by Type
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPOs)
Segment by Application
  • Premarketing Clinical Trial
  • Post-marketing Clinical Practice
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation, iMED Global Corporation, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PharmInvent, PrimeVigilance, Pure Drug Safety, Sciformix, SIRO Clinpharm, Symogen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Pharmacovigilance (PV) Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance (PV) Outsourcing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Pharmacovigilance (PV) Outsourcing Market report?

Ans: The main players in the Pharmacovigilance (PV) Outsourcing Market are Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation, iMED Global Corporation, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PharmInvent, PrimeVigilance, Pure Drug Safety, Sciformix, SIRO Clinpharm, Symogen

What are the Application segmentation covered in the Pharmacovigilance (PV) Outsourcing Market report?

Ans: The Applications covered in the Pharmacovigilance (PV) Outsourcing Market report are Premarketing Clinical Trial, Post-marketing Clinical Practice, Other

What are the Type segmentation covered in the Pharmacovigilance (PV) Outsourcing Market report?

Ans: The Types covered in the Pharmacovigilance (PV) Outsourcing Market report are Contract Research Organizations (CROs), Business Process Outsourcing (BPOs)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Contract Research Organizations (CROs)
1.2.3 Business Process Outsourcing (BPOs)
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Premarketing Clinical Trial
1.3.3 Post-marketing Clinical Practice
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2019-2030)
2.2 Global Pharmacovigilance (PV) Outsourcing Growth Trends by Region
2.2.1 Pharmacovigilance (PV) Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2019-2024)
2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2025-2030)
2.3 Pharmacovigilance (PV) Outsourcing Market Dynamics
2.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends
2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers
2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges
2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmacovigilance (PV) Outsourcing by Players
3.1.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2019-2024)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmacovigilance (PV) Outsourcing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2023
3.5 Global Key Players of Pharmacovigilance (PV) Outsourcing Head office and Area Served
3.6 Global Key Players of Pharmacovigilance (PV) Outsourcing, Product and Application
3.7 Global Key Players of Pharmacovigilance (PV) Outsourcing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2019-2024)
4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2025-2030)
5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2019-2024)
5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
6.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type
6.2.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024)
6.2.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030)
6.2.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Application
6.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024)
6.3.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030)
6.3.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country
6.4.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
6.4.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
7.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type
7.2.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024)
7.2.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030)
7.2.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application
7.3.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024)
7.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030)
7.3.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country
7.4.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
7.4.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
8.2 China Pharmacovigilance (PV) Outsourcing Market Size by Type
8.2.1 China Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024)
8.2.2 China Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030)
8.2.3 China Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
8.3 China Pharmacovigilance (PV) Outsourcing Market Size by Application
8.3.1 China Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024)
8.3.2 China Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030)
8.3.3 China Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
9.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Type
9.2.1 Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024)
9.2.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030)
9.2.3 Asia Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
9.3 Asia Pharmacovigilance (PV) Outsourcing Market Size by Application
9.3.1 Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024)
9.3.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030)
9.3.3 Asia Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
9.4 Asia Pharmacovigilance (PV) Outsourcing Market Size by Region
9.4.1 Asia Pharmacovigilance (PV) Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024)
9.4.3 Asia Pharmacovigilance (PV) Outsourcing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Accenture
11.1.1 Accenture Company Details
11.1.2 Accenture Business Overview
11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction
11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.1.5 Accenture Recent Developments
11.2 C3i Solutions
11.2.1 C3i Solutions Company Details
11.2.2 C3i Solutions Business Overview
11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction
11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.2.5 C3i Solutions Recent Developments
11.3 Clintec
11.3.1 Clintec Company Details
11.3.2 Clintec Business Overview
11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction
11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.3.5 Clintec Recent Developments
11.4 Covance
11.4.1 Covance Company Details
11.4.2 Covance Business Overview
11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction
11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.4.5 Covance Recent Developments
11.5 Deloitte Touche Tohmatsu Limited
11.5.1 Deloitte Touche Tohmatsu Limited Company Details
11.5.2 Deloitte Touche Tohmatsu Limited Business Overview
11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction
11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
11.6 ELC Group
11.6.1 ELC Group Company Details
11.6.2 ELC Group Business Overview
11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction
11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.6.5 ELC Group Recent Developments
11.7 Ergomed
11.7.1 Ergomed Company Details
11.7.2 Ergomed Business Overview
11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction
11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.7.5 Ergomed Recent Developments
11.8 iGATE Corporation
11.8.1 iGATE Corporation Company Details
11.8.2 iGATE Corporation Business Overview
11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.8.5 iGATE Corporation Recent Developments
11.9 iMED Global Corporation
11.9.1 iMED Global Corporation Company Details
11.9.2 iMED Global Corporation Business Overview
11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.9.5 iMED Global Corporation Recent Developments
11.10 IQVIA
11.10.1 IQVIA Company Details
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction
11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.10.5 IQVIA Recent Developments
11.11 MarksMan Healthcare
11.11.1 MarksMan Healthcare Company Details
11.11.2 MarksMan Healthcare Business Overview
11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction
11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.11.5 MarksMan Healthcare Recent Developments
11.12 Medpace Holdings
11.12.1 Medpace Holdings Company Details
11.12.2 Medpace Holdings Business Overview
11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction
11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.12.5 Medpace Holdings Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction
11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.13.5 Novartis Recent Developments
11.14 Oracle Corporation
11.14.1 Oracle Corporation Company Details
11.14.2 Oracle Corporation Business Overview
11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.14.5 Oracle Corporation Recent Developments
11.15 Parexel
11.15.1 Parexel Company Details
11.15.2 Parexel Business Overview
11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction
11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.15.5 Parexel Recent Developments
11.16 PharmInvent
11.16.1 PharmInvent Company Details
11.16.2 PharmInvent Business Overview
11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction
11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.16.5 PharmInvent Recent Developments
11.17 PrimeVigilance
11.17.1 PrimeVigilance Company Details
11.17.2 PrimeVigilance Business Overview
11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction
11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.17.5 PrimeVigilance Recent Developments
11.18 Pure Drug Safety
11.18.1 Pure Drug Safety Company Details
11.18.2 Pure Drug Safety Business Overview
11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction
11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.18.5 Pure Drug Safety Recent Developments
11.19 Sciformix
11.19.1 Sciformix Company Details
11.19.2 Sciformix Business Overview
11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction
11.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.19.5 Sciformix Recent Developments
11.20 SIRO Clinpharm
11.20.1 SIRO Clinpharm Company Details
11.20.2 SIRO Clinpharm Business Overview
11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction
11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.20.5 SIRO Clinpharm Recent Developments
11.21 Symogen
11.21.1 Symogen Company Details
11.21.2 Symogen Business Overview
11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction
11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.21.5 Symogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Accenture Plc
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
Igate Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
ORACLE CORPORATION
PAREXEL
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
List of Tables
    Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Contract Research Organizations (CROs)
    Table 3. Key Players of Business Process Outsourcing (BPOs)
    Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2019-2024)
    Table 8. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2025-2030)
    Table 10. Pharmacovigilance (PV) Outsourcing Market Trends
    Table 11. Pharmacovigilance (PV) Outsourcing Market Drivers
    Table 12. Pharmacovigilance (PV) Outsourcing Market Challenges
    Table 13. Pharmacovigilance (PV) Outsourcing Market Restraints
    Table 14. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Players (2019-2024)
    Table 16. Global Top Pharmacovigilance (PV) Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2023)
    Table 17. Global Pharmacovigilance (PV) Outsourcing Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Pharmacovigilance (PV) Outsourcing, Headquarters and Area Served
    Table 20. Global Key Players of Pharmacovigilance (PV) Outsourcing, Product and Application
    Table 21. Global Key Players of Pharmacovigilance (PV) Outsourcing, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2019-2024)
    Table 25. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2025-2030)
    Table 27. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2019-2024)
    Table 29. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2025-2030)
    Table 31. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Pharmacovigilance (PV) Outsourcing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Pharmacovigilance (PV) Outsourcing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Pharmacovigilance (PV) Outsourcing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Pharmacovigilance (PV) Outsourcing Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Accenture Company Details
    Table 64. Accenture Business Overview
    Table 65. Accenture Pharmacovigilance (PV) Outsourcing Product
    Table 66. Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 67. Accenture Recent Developments
    Table 68. C3i Solutions Company Details
    Table 69. C3i Solutions Business Overview
    Table 70. C3i Solutions Pharmacovigilance (PV) Outsourcing Product
    Table 71. C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 72. C3i Solutions Recent Developments
    Table 73. Clintec Company Details
    Table 74. Clintec Business Overview
    Table 75. Clintec Pharmacovigilance (PV) Outsourcing Product
    Table 76. Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 77. Clintec Recent Developments
    Table 78. Covance Company Details
    Table 79. Covance Business Overview
    Table 80. Covance Pharmacovigilance (PV) Outsourcing Product
    Table 81. Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 82. Covance Recent Developments
    Table 83. Deloitte Touche Tohmatsu Limited Company Details
    Table 84. Deloitte Touche Tohmatsu Limited Business Overview
    Table 85. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product
    Table 86. Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 87. Deloitte Touche Tohmatsu Limited Recent Developments
    Table 88. ELC Group Company Details
    Table 89. ELC Group Business Overview
    Table 90. ELC Group Pharmacovigilance (PV) Outsourcing Product
    Table 91. ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 92. ELC Group Recent Developments
    Table 93. Ergomed Company Details
    Table 94. Ergomed Business Overview
    Table 95. Ergomed Pharmacovigilance (PV) Outsourcing Product
    Table 96. Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 97. Ergomed Recent Developments
    Table 98. iGATE Corporation Company Details
    Table 99. iGATE Corporation Business Overview
    Table 100. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product
    Table 101. iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 102. iGATE Corporation Recent Developments
    Table 103. iMED Global Corporation Company Details
    Table 104. iMED Global Corporation Business Overview
    Table 105. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product
    Table 106. iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 107. iMED Global Corporation Recent Developments
    Table 108. IQVIA Company Details
    Table 109. IQVIA Business Overview
    Table 110. IQVIA Pharmacovigilance (PV) Outsourcing Product
    Table 111. IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 112. IQVIA Recent Developments
    Table 113. MarksMan Healthcare Company Details
    Table 114. MarksMan Healthcare Business Overview
    Table 115. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product
    Table 116. MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 117. MarksMan Healthcare Recent Developments
    Table 118. Medpace Holdings Company Details
    Table 119. Medpace Holdings Business Overview
    Table 120. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product
    Table 121. Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 122. Medpace Holdings Recent Developments
    Table 123. Novartis Company Details
    Table 124. Novartis Business Overview
    Table 125. Novartis Pharmacovigilance (PV) Outsourcing Product
    Table 126. Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 127. Novartis Recent Developments
    Table 128. Oracle Corporation Company Details
    Table 129. Oracle Corporation Business Overview
    Table 130. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product
    Table 131. Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 132. Oracle Corporation Recent Developments
    Table 133. Parexel Company Details
    Table 134. Parexel Business Overview
    Table 135. Parexel Pharmacovigilance (PV) Outsourcing Product
    Table 136. Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 137. Parexel Recent Developments
    Table 138. PharmInvent Company Details
    Table 139. PharmInvent Business Overview
    Table 140. PharmInvent Pharmacovigilance (PV) Outsourcing Product
    Table 141. PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 142. PharmInvent Recent Developments
    Table 143. PrimeVigilance Company Details
    Table 144. PrimeVigilance Business Overview
    Table 145. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product
    Table 146. PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 147. PrimeVigilance Recent Developments
    Table 148. Pure Drug Safety Company Details
    Table 149. Pure Drug Safety Business Overview
    Table 150. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product
    Table 151. Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 152. Pure Drug Safety Recent Developments
    Table 153. Sciformix Company Details
    Table 154. Sciformix Business Overview
    Table 155. Sciformix Pharmacovigilance (PV) Outsourcing Product
    Table 156. Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 157. Sciformix Recent Developments
    Table 158. SIRO Clinpharm Company Details
    Table 159. SIRO Clinpharm Business Overview
    Table 160. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product
    Table 161. SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 162. SIRO Clinpharm Recent Developments
    Table 163. Symogen Company Details
    Table 164. Symogen Business Overview
    Table 165. Symogen Pharmacovigilance (PV) Outsourcing Product
    Table 166. Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024) & (US$ Million)
    Table 167. Symogen Recent Developments
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2023 VS 2030
    Figure 3. Contract Research Organizations (CROs) Features
    Figure 4. Business Process Outsourcing (BPOs) Features
    Figure 5. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2023 VS 2030
    Figure 7. Premarketing Clinical Trial Case Studies
    Figure 8. Post-marketing Clinical Practice Case Studies
    Figure 9. Other Case Studies
    Figure 10. Pharmacovigilance (PV) Outsourcing Report Years Considered
    Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2023 VS 2030
    Figure 14. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2023
    Figure 15. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2023
    Figure 17. North America Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
    Figure 19. North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
    Figure 20. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)
    Figure 21. United States Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Pharmacovigilance (PV) Outsourcing Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
    Figure 25. Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
    Figure 26. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)
    Figure 27. Germany Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Pharmacovigilance (PV) Outsourcing Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
    Figure 35. China Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
    Figure 36. Asia Pharmacovigilance (PV) Outsourcing Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
    Figure 38. Asia Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
    Figure 39. Asia Pharmacovigilance (PV) Outsourcing Market Share by Region (2019-2030)
    Figure 40. Japan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Pharmacovigilance (PV) Outsourcing Market Share by Country (2019-2030)
    Figure 50. Brazil Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 57. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 58. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 59. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 60. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 61. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 62. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 63. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 64. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 65. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 66. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 67. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 68. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 69. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 70. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 71. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 72. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 73. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 74. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 75. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 76. Symogen Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions